Detailed Information on Publication Record
2022
Phenotypic spectrum of the SCN1A mutation (from febrile seizures to Dravet syndrome)
ČESKÁ, Katarína, Pavlína DANHOFER, Ondřej HORÁK, Klára ŠPANĚLOVÁ, Senad KOLÁŘ et. al.Basic information
Original name
Phenotypic spectrum of the SCN1A mutation (from febrile seizures to Dravet syndrome)
Authors
ČESKÁ, Katarína (703 Slovakia, belonging to the institution), Pavlína DANHOFER (203 Czech Republic, belonging to the institution), Ondřej HORÁK (203 Czech Republic, belonging to the institution), Klára ŠPANĚLOVÁ (203 Czech Republic, belonging to the institution), Senad KOLÁŘ (203 Czech Republic, belonging to the institution), Hana OŠLEJŠKOVÁ (203 Czech Republic, belonging to the institution) and Štefánia AULICKÁ (703 Slovakia, belonging to the institution)
Edition
Bratislava Medical Journal - Bratislavské lekárske listy, BRATISLAVA, Univerzita Komenského, 2022, 0006-9248
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30210 Clinical neurology
Country of publisher
Slovakia
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.500
RIV identification code
RIV/00216224:14110/22:00128262
Organization unit
Faculty of Medicine
UT WoS
000812277000004
Keywords in English
Dravet's syndrome; sodium channel; functional analysis; prognosis
Tags
International impact, Reviewed
Změněno: 2/2/2023 13:48, Mgr. Tereza Miškechová
Abstract
V originále
Dravet's syndrome previously known as severe myoclonic epilepsy in infancy, is classified as epilepsy on a genetic basis (1). 70???80 % of the patients with the Dravet???s syndrome phenotype are associated with the detection of a sequence variant in the SCN1A gene (alpha 1 subunit of the voltage-gated sodium channel) (2). However, sequence variants in the SCN1A gene are associated with a very broad clinical spectrum, from asymptomatic carriers to the severe myoclonic epilepsy phenotype with severe disease (3). In the presented work, we retrospectively evaluated a group of 6 patients of the Department of Pediatric Neurology of the Medical Faculty of Masaryk University and the University Hospital in Brno with a proven missense mutation. Based on the specific pathogenic sequence variant, we correlated the patient???s phenotype with the location of the sequence variant in the SCN1A gene. The aim of the analysis was to verify the extent, to which the storage of a pathogenic sequence variant in the SCN1A gene corresponds to the clinical picture of the patient (Tab. 2, Fig. 2, Ref. 10). Text in PDF www.elis.sk